Phenotypic and Molecular Detection of Antiseptic Resistance Genes among Clinical Staphylococcus aureus Isolates during COVID-19 Pandemic

Bibliographic Information
Authors: Badawi H.; Reda A.; El Said M.; El-Far A.; Magdy R.; El-Shenawy A.; Yousry N.
Journal: Journal of Pure and Applied Microbiology
Publisher: Journal of Pure and Applied Microbiology
Publication Date: 1 November 2022
Volume / Issue: Volume 16 / Issue 4
Pages: 2619–2630
ISSN: 9737510
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access
Authors and Affiliations
Badawi H., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt; Reda A., Department of Microbiology & Immunology, Faculty of Medicine, Cairo University, Egypt; El Said M., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt, Department of Microbiology, Medicine Program, Batterjee Medical College, Jeddah, 21442, Saudi Arabia; El-Far A., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt; Magdy R., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt; El-Shenawy A., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt; Yousry N., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt
Abstract
The coronavirus disease (COVID-19) pandemic has expanded the use of chlorhexidine digluconate, a biocide frequently used in hospitals, to inhibit the spread of infection. Genes responsible for resistance against the quaternary ammonium compound qac in Staphylococcus aureus isolates have been shown to confer tolerance to a number of biocidal chemicals, including chlorhexidine. The aim of this study was to determine the occurrence of antiseptic resistance genes (qacA/B and qacC) in clinical isolates of methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). The study also aimed to investigate the association between the presence of the mecA, qacA/B, and qacC genes in MRSA isolates and the susceptibility of the isolates to chlorhexidine to evaluate its future use in the Theodor Bilharz Research Institute (TBRI) hospital, following the Centers for Disease Control and Prevention recommendations for patients with MRSA. S. aureus isolates (n = 100) were collected from inpatients and outpatients at TBRI. A minimal inhibitory concentration of chlorhexidine was also detected. Polymerase chain reaction was used to detect the mecA, qacA/B, and qacC genes. The results revealed that 84% of S. aureus isolates were MRSA. MRSA (61.9%) and MSSA (68.8%) isolates were susceptible to chlorhexidine. The qacA/B gene was more dominant, being detected in 34%, while qacC was detected in only 5% of S. aureus isolates. All S. aureus isolates with reduced susceptibility to chlorhexidine harbored either the qacA/B or qacC genes. The clinical use of chlorhexidine may continue to increase, emphasizing the significance of continuous caution underlining the emergence of new clones with reduced susceptibility and avoiding antiseptic misuse. © The Author(s) 2022.
Keywords
Antiseptic Resistance; Chlorhexidine; MRSA; MSSA; qacA/B; qacC Genes; Staphylococcus aureus; catalase; cefoxitin; ciprofloxacin; clindamycin; coagulase; cotrimoxazole; erythromycin; gentamicin; glycerol; linezolid; mannitol; membrane protein; meticillin; moxifloxacin; oxacillin; penicillin binding protein 2a; qaca protein; qacb protein; qacc protein; quaternary ammonium derivative; unclassified drug; vancomycin; adult; Article; bacterium isolate; clinical evaluation; controlled study; coronavirus disease 2019; disease association; disease control; genetic resistance; genetic susceptibility; hand washing; hospital patient; human; human tissue; infection prevention; methicillin resistant Staphylococcus aureus; methicillin susceptible Staphylococcus aureus; microbiological examination; minimum inhibitory concentration; outpatient care; pandemic; phenotypic variation; polymerase chain reaction
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
